LBEL DERMO CLARITE BRIGHTENING AND MOISTURIZING FACIAL SPF 30

Manufacturer
Ventura Corporation LTD | Bel Star S.A. (Colombia)
Effective date
2019-11-17
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
legacy-cache
Hydrated at
2026-08-02 00:00:55

Label at a glance#

ProductLBEL DERMO CLARITE BRIGHTENING AND MOISTURIZING FACIAL SPF 30
Active ingredientAvobenzone, Octisalate, Octocrylene
Label structure9 sections

Indications and uses

Helps prevent sunburn.

Dosage and administration

Apply liberally and evenly 15 minutes before sun exposure. Reapply at least every 2 hours Use a water resistant sunscreen if swimming or sweating. Children under 6 months of age: Ask a doctor

Storage and handling

Protect the product in this container from excessive heat and direct sun.

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Drug Facts

OTC - ACTIVE INGREDIENT SECTION

OTC - PURPOSE SECTION

Active IngredientsPurpose
Avobenzone 1.80 %Sunscreen
Octisalate 4.50 %Sunscreen
Octocrylene 4.50 %Sunscreen

Uses

INDICATIONS & USAGE SECTION

  • Helps prevent sunburn.

Warnings

WARNINGS SECTION

SPL UNCLASSIFIED SECTION

  • Skin Cancer / Skin Aging Alert: Spending time in the sun increases your risk of skin cancer and early skin aging. This product has been shown only to help prevent sunburn, not skin cancer or early skin aging.
  • For external use only.

OTC - DO NOT USE SECTION

  • Do not use on damaged or broken skin.

OTC - WHEN USING SECTION

  • When using this product keep out of eyes. Rinse with water to remove.

OTC - STOP USE SECTION

  • Stop use and ask a doctor if rash occurs.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

  • Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

  • Apply liberally and evenly 15 minutes before sun exposure.
  • Reapply at least every 2 hours
  • Use a water resistant sunscreen if swimming or sweating.
  • Children under 6 months of age: Ask a doctor

Other information

STORAGE AND HANDLING SECTION

  • Protect the product in this container from excessive heat and direct sun.

Inactive ingredients

INACTIVE INGREDIENT SECTION

WATER, GLYCERIN, C12-15 ALKYL BENZOATE, BUTYLOCTYL SALICYLATE, CYCLOHEXASILOXANE, ETHYLHEXYL METHOXYCRYLENE, POTASSIUM CETYL PHOSPHATE, TRIETHYLHEXANOIN, HYDROGENATED PALM GLYCERIDES, GLYCERYL STEARATE, PEG-100 STEARATE, SYNTHETIC FLUORPHLOGOPITE, HYDROXYACETOPHENONE, TITANIUM DIOXIDE, ACRYLATES/C10-30 ALKYL ACRYLATE CROSSPOLYMER, VIGNA ACONITIFOLIA SEED EXTRACT, XANTHAN GUM, 1,2-HEXANEDIOL, CAPRYLYL GLYCOL, DIMETHYLMETHOXY CHROMANYL PALMITATE, CETEARYL ISONONANOATE, SODIUM COCOYL GLUTAMATE, ACACIA SENEGAL GUM, TETRASODIUM EDTA, CETEARETH-20, CETEARYL ALCOHOL, SODIUM HYDROXIDE, HYDROLYZED ALGIN, CETEARETH-12, CETYL PALMITATE, PHENOXYETHANOL, TIN OXIDE

SPL UNCLASSIFIED SECTION

Dist. by Ventura Corp Ltd.,
San Juan, Puerto Rico 00926.

PRINCIPAL DISPLAY PANEL - 30 ml Jar Carton

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

L'BEL

DERMO
CLARITÉ

brightening and
moisturizing facial
lotion SPF 30

30 ml e (1 fl.oz.)

PRINCIPAL DISPLAY PANEL - 30 ml Jar Carton
PRINCIPAL DISPLAY PANEL - 30 ml Jar Carton

FDA-Initiated Inactive NDC Indexing#

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 33 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
43596-008843596-0088-1, 43596-0088-2

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 31 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
323937fb-fab2-4300-e063-6294a90af6fbda37b1f6-2453-4e24-a0af-ef12eeec269e2025-04-07WarningsExact identifier
spl set id: da37b1f6-2453-4e24-a0af-ef12eeec269e

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.